Haploidentical stem cell transplantation for the treatment of leukemia: current status.

about

Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factors.

P2860

Q40361692-E5B575C6-5555-4ABB-8A79-C2AFE9211BF3

P2860

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

Item

http://www.wikidata.org/entity/Q38248521

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

@en

type

Item

label

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

@en

prefLabel

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

@en

P1476

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

@en

P2093

Ying-Jun Chang

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene

HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

P304

635-647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1586/17474086.2014.954543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiao-Jun Huang

P577

2014-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25213459

http://www.w3.org/2001/XMLSchema#string

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

about

P2860

P2860

Haploidentical stem cell transplantation for the treatment of leukemia: current status.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698